🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test how BMS-247550 (ixabepilone) affects t...
Status
Completed
Location
Local Institution
Start Date
2004-10
Trial ID
NCT00207129
Treatments Being Tested
The purpose of this clinical research study is to learn if BMS-247550 added...
Status
Completed
Location
Local Institution
Start Date
2003-11
Trial ID
NCT00082433
Treatments Being Tested
The purpose of this clinical research study is to learn if BMS-247550 added...
Status
Completed
Location
Local Institution
Start Date
2003-09
Trial ID
NCT00080301
Treatments Being Tested
The purpose of this study is to determine the safety and preliminary effect...
Status
Terminated
Location
The Cancer Institute Of New Jersey
Start Date
2008-06
Trial ID
NCT00634088
The purpose of this research study is to assess the response rate of the in...
Status
Completed
Location
Local Institution
Start Date
2004-02
Trial ID
NCT00080262
Treatments Being Tested
To determine safety and maximum tolerated dose of brivanib alaninate when a...
Status
Completed
Location
Usc/Norris Comprehensive Cancer Center
Start Date
2009-03
Trial ID
NCT00798252
Treatments Being Tested
In 2008 there were more than 40,000 deaths caused by metastatic breast canc...
Status
Withdrawn
Location
Thomas Jefferson University
Start Date
2013-12
Trial ID
NCT01349088
Treatments Being Tested
The study is designed as an open-label, randomized, parallel, two arm, mult...
Status
Completed
Location
Arizona Oncology Associates, PC - NAHOA
Start Date
2011-12
Trial ID
NCT01492101
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Unknown
Location
Jonsson Comprehensive Cancer Center, UCLA
Start Date
2002-09
Trial ID
NCT00049244
Treatments Being Tested
This is an open-label, randomized, active comparator, multicenter, internat...
Status
Completed
Location
Investigator Site - Tucson
Start Date
2016-11
Trial ID
NCT02915744
Treatments Being Tested